Mantis Biotech is creating ‘digital twins’ of humans to help address medicine’s data availability problem
MANTIS BIOTECH IS DEVELOPING DIGITAL TWINS FOR MEDICAL INNOVATION
New York-based Mantis Biotech is at the forefront of medical innovation with its groundbreaking development of digital twins—advanced, physics-based models that replicate human anatomy, physiology, and behavior. These digital twins represent a significant leap forward in how medical research and clinical practices can be enhanced through technology. By creating virtual replicas of human bodies, Mantis Biotech aims to provide healthcare professionals with powerful tools that can improve patient outcomes and streamline medical processes.
HOW MANTIS BIOTECH IS ADDRESSING THE DATA AVAILABILITY PROBLEM IN MEDICINE
The healthcare sector is often plagued by a critical issue: the availability of reliable and representative data. While large language models have the potential to revolutionize biomedical research, they frequently encounter challenges when dealing with rare diseases and atypical conditions where data is scarce. Mantis Biotech is tackling this data availability problem head-on. By developing synthetic datasets derived from various data sources, the company aims to fill the gaps that currently hinder effective medical research and decision-making.
MANTIS BIOTECH IS INTEGRATING DISPARATE DATA SOURCES FOR SYNTHETIC DATASETS
To create its digital twins, Mantis Biotech employs a sophisticated platform that integrates disparate sources of data. This integration is crucial for generating synthetic datasets that accurately reflect human biology and behavior. By combining structured data with insights from various healthcare settings, Mantis Biotech is able to produce comprehensive models that can be used for a variety of applications, including the simulation of medical procedures and the training of surgical robots. This innovative approach not only enhances the quality of the data available for research but also enables healthcare professionals to make more informed decisions.
THE ROLE OF DIGITAL TWINS IN MANTIS BIOTECH'S MEDICAL SOLUTIONS
Digital twins are set to play a pivotal role in Mantis Biotech's medical solutions. These virtual models can be utilized for data aggregation and analysis, allowing researchers and clinicians to study and test new medical procedures in a risk-free environment. For instance, a sports team could leverage these digital twins to assess the likelihood of an athlete sustaining an injury based on various factors such as performance metrics, training loads, and dietary habits. By simulating different scenarios, Mantis Biotech's digital twins can provide valuable insights that contribute to proactive healthcare strategies.
HOW MANTIS BIOTECH IS USING DIGITAL TWINS TO PREDICT MEDICAL OUTCOMES
Mantis Biotech's innovative use of digital twins extends to predicting medical outcomes, a capability that could transform patient care. By analyzing the synthetic datasets created from integrated data sources, the company can forecast potential health issues and patterns of behavior. For example, the digital twin of an NFL player could be used to predict the likelihood of developing an Achilles heel injury, thereby allowing for preventive measures to be implemented. This predictive power not only enhances individual patient care but also has the potential to inform broader public health strategies.